clinical efficacy and safety of biodegradable magnesium needle patch

clinical efficacy and safety of magnesium needle patch

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0007663

Enrollment

Registered

2022-08-30

Start date

2021-01-11

Completion date

Unknown

Last updated

2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : APPLICATION OF Mg MN PATCH ON INFLAMMATORY ACNES AND PORES.(PILOT STUDY)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with mild to moderate acne and between the ages of 20 to 40 years who were not taking any anti-acne oral medication

Exclusion criteria

Exclusion criteria: Patients who were taking any oral medication for acne treatment Patients who were treated with botulinum toxin, HIFU, or lasers within 6 months before screening Patients who underwent HA filler treatment within 1 year before screening Patients who have plans for filler, laser, skin resurfacing, fat transplantation during the study period Patients who are on any medications or disease which may influence the results using Mg Women who were pregnant or lactating Patients who do not agree with the contraception during the study period (12 weeks)

Design outcomes

Primary

Measure	Time frame
acne score/	—

Secondary

Measure	Time frame
pore size.sebum secretion/porphyrin level	—

Countries

Korea, Republic of

Contacts

Public ContactJong Hee Lee

Samsung Medical Center

bell711@hanmail.net+82-2-3410-3549

Outcome results